The future role of the ophthalmologist in diabetic retinopathy (DR) care will be focused on consultations of difficult and complicated cases and their treatment.

Telemedicine augmented by artificial intelligence (AI) will make the DR screening system more effective and cheaper, with better coverage of the diabetic population.

The screening of DR will be done by eye technicians, general practitioners or by patients themselves supported by AI.